These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2947253)

  • 1. Influence of nalmefene on energy balance and glucose regulation in Zucker rats.
    McLaughlin CL; Baile CA; Gingerich RL; Michel ME
    Physiol Behav; 1986; 37(6):899-908. PubMed ID: 2947253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats.
    McLaughlin CL; Baile CA
    Pharmacol Biochem Behav; 1983 Aug; 19(2):235-40. PubMed ID: 6634872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
    Recant L; Voyles NR; Luciano M; Pert CB
    Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate antagonists and eating behavior in humans: a review.
    de Zwaan M; Mitchell JE
    J Clin Pharmacol; 1992 Dec; 32(12):1060-72. PubMed ID: 1487543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating.
    Jarosz PA; Metzger BL
    Biol Res Nurs; 2002 Apr; 3(4):198-209. PubMed ID: 12184663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
    June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of kappa opioid receptor antagonism on energy expenditure in the obese Zucker rat.
    Jarosz PA
    Biol Res Nurs; 2007 Apr; 8(4):294-9. PubMed ID: 17456590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats.
    Picard F; Deshaies Y; Lalonde J; Samson P; Richard D
    Obes Res; 2000 Dec; 8(9):656-63. PubMed ID: 11225714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats.
    Vink R; McIntosh TK; Rhomhanyi R; Faden AI
    J Neurosci; 1990 Nov; 10(11):3524-30. PubMed ID: 2230942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM; Koob GF
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of beta-endorphin in exercise-induced improvement in insulin resistance in obese Zucker rats.
    Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT
    Diabetes Metab Res Rev; 2005; 21(2):175-82. PubMed ID: 15386812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice.
    Chen RZ; Huang RR; Shen CP; MacNeil DJ; Fong TM
    Brain Res; 2004 Mar; 999(2):227-30. PubMed ID: 14759503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin modifies prolactin release induced by opiate antagonists in male rats.
    Shacoori V; Saiag B; Rault B
    Endocr Res; 1995 Aug; 21(3):545-53. PubMed ID: 7588425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of morphine and nalmefene on energy balance in diabetic and non-diabetic rats.
    Levine AS; Grace M; Billington CJ; Gosnell BA; Krahn DD; Brown DM; Morley JE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):495-500. PubMed ID: 3362942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
    Faden AI; Sacksen I; Noble LJ
    J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meal-stimulated increased concentrations of beta-endorphin in the hypothalamus of Zucker obese and lean rats.
    McLaughlin CL; Baile CA; Della-Fera MA
    Physiol Behav; 1985 Dec; 35(6):891-6. PubMed ID: 2937072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
    Simpkins JW; Smulkowski M; Dixon R; Tuttle R
    J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic administration of nalmefene leads to increased food intake and body weight gain in mice.
    Chen RZ; Huang RR; Shen CP; MacNeil DJ; Fong TM
    Eur J Pharmacol; 2004 Jul; 495(1):63-6. PubMed ID: 15219821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunization against beta-endorphin increases food intakes and body weights of obese rats.
    McLaughlin CL; Baile CA
    Physiol Behav; 1985 Sep; 35(3):365-70. PubMed ID: 2933753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C; Samson P; Lalonde J; Richard D
    J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.